Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

BrightGene Bio-Medical Technology Co · Phase 2 · Recruiting · Enrollment 200

NCT07658560

ArmPopulationDoseWeeksEstimandWeight change
The dose1 groupObesity, no T2Dn/r20n/rn/r
The dose2 groupObesity, no T2Dn/r20n/rn/r
The dose3 groupObesity, no T2Dn/r20n/rn/r
The dose4 groupObesity, no T2Dn/r20n/rn/r
Placebo groupObesity, no T2Dn/r20n/rn/r